Abstract:Background Celiac disease is a chronic autoimmune pathology that affects people with genetic predisposition, caused by a permanent intolerance to gluten. Its prevalence has been estimated at around 1% but about 30% of patients are diagnosed after age 60.Its diagnosis is made through clinical data, serological markers, study of duodenal biopsy (BD) and response to the gluten-free diet. The histological study (Marsh classification) remains the gold standard to the diagnosis and allows classification of the disease in 4 types: grade I (less histological lesion) to grade IV (total duodenal mucosal atrophy).In these patients the deficiency of 25-OH vitamin D (vit D) is very frequent and is one of the causes of osteomalacia associated with malabsorption. Objectives To evaluate if there is a relation between the histological classification of Marsh and the bone metabolism in patients with a recent diagnosis of celiac disease. Methods Prospective study, which included all patients with a recent diagnosis of celiac disease by the Digestive Service during the period 2014–2016. This diagnosis was made through a clinical, serological (anti-transglutaminase IgA, anti-endomysium IgA), histological BD and genetic study (HLA DQ2 and HLA DQ8). All patients underwent a study of phospho-calcium metabolism including: calcemia, phosphataemia, vit D, PTH, alkaline phosphatases, 24-hour calciuria and a densitometric study (BMD). We present the inclusion data of these patients Results 15 patients were included: 11 women and 4 men, with a mean age of 42.2 years (SD+/-16) The genetic study was performed in 12 patients: 75% were positive for HLA DQ2 and 25% for HLA DQ8. The determination of antibodies was positive in 12 patients (73%) and negative in 3 (27%). These 3 were positive for the genetic study (2 HLA DQ2 and 1 HLA DQ8). The study of BD showed: type I in 4 patients; Type IIIa in 2 patients; Type IIIb in 6 patients; Type IIIC in 3 patients. BMD showed normal values in 33%, osteopenia in 47% and osteoporosis (OP) in 20% of patients. Thus, 67% had an alteration in BMD at the time of diagnosis. 100% had a Vit D deficit, with a mean value of 14.3 ng/mL (range 4.15–26.8). 75% of them had values below 20 ng/mL (40% less than 10 ng/mL). 40% had secondary hyperparathyroidism (SHP), 83% of which had an alteration in BMD (67% osteopenia and 16% OP). The BD of the patients with SHP and alteration of the BMD showed a histological pattern type Marsh III. No patient presented an alteration in the values of calcemia, phosphataemia or calciuria. The relationship between the degree of alteration in BMD and the Marsh classification (table) was studied. 72% of patients with a Marsh III had an alteration in BMD (3 OP and 5 osteopenia vs 3 normal). DMO Marsh I Marsh IIIa Marsh IIIB Marsh IIIc Total Osteoporosi 0 0 2 1 3 Osteopenia 2 2 1 2 7 Normal 2 0 3 0 5 Total 4 2 6 3 15 Conclusions Most patients with celiac disease have an alteration in BMD. In our study, all patients with celiac disease had a Vit D deficiency with no alteration of calcemia or calciuria. Only in patients with SHP, there is a correlation between alterations in BMD and a higher degree of Marsh. Most patients with a histological Marsh III have abnormalities in BMD. Disclosure of Interest None declared

Celiac Disease Investigation with Marsh Classification in Paediatric Population

Clinical Presentation of Pediatric Celiac Disease Patients in the Qassim Region Over Recent Years

In Celiac disease: Type 3a, 3b and grade BI is more frequent on Marsh Modified (Oberhuber) / Corraza classification.

AB0843 Relationship between the histological classification of marsh and the affectation of the bone metabolism in patients with a recent diagnosis of celiac disease

Clinical Spectrum of Celiac Disease among Adult Population: Experience from Largest Tertiary Care Hospital in Karachi, Pakistan

Clinical biochemical and serological profile in Children with Celiac disease

Clinical manifestations and associated disorders in children with celiac disease in southern Iran

Prevalence of Esophageal Eosinophilia, Eosinophilic Esophagitis, and Lymphocytic Gastritis in Children with Celiac Disease: A Saudi Tertiary Center Experience

Extra-intestinal manifestations of Celiac disease in children: their prevalence and association with human leukocyte antigens and pathological and laboratory evaluations

Evaluation and treatment of celiac disease in the central and south of Iraq

Celiac Disease on the Bed-Side: Embedding Case Finding and Screening in Hospitalized Children

Microbiota profile of new-onset celiac disease in children in Saudi Arabia

Gut microbiota predicts the diagnosis of celiac disease in Saudi children

Clinical Spectrum in a Cohort of Patients With High Fecal Calprotectin Levels

Feasibility of a "No-Biopsy" Approach for the Diagnosis of Celiac Disease in Symptomatic Adults

Celiac disease in children: A review of the literature

Quantitative histology-based classification system for assessment of the intestinal mucosal histological changes in patients with celiac disease

Clinical, biochemical and radiological findings in children with glycogen storage disease.

Immunoglobulin E-Mediated Food Sensitization in a Moroccan Pediatric Population with Celiac Disease

Celiac Disease in Children: A 2023 Update

Clinical Presentation of Celiac Disease and Diagnosis Accuracy in a Single-Center European Pediatric Cohort over 10 Years